Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun;53(12):1323.
doi: 10.1111/apt.16384.

Editorial: determining disability in inflammatory bowel disease-"See(k) and you shall find". Authors' reply

Jenny Tannoury  1 , Aurelien Amiot  1
Affiliations
Editorial

Editorial: determining disability in inflammatory bowel disease-"See(k) and you shall find". Authors' reply

Jenny Tannoury et al. Aliment Pharmacol Ther. 2021 Jun.
No abstract available

PubMed Disclaimer

Comment on

  • Determinants of IBD-related disability: a cross-sectional survey from the GETAID.
    Tannoury J, Nachury M, Martins C, Serrero M, Filippi J, Roblin X, Bourrier A, Bouguen G, Franchimont D, Savoye G, Buisson A, Louis E, Nancey S, Abitbol V, Reimund JM, DeWitt O, Vuitton L, Mathieu N, Peyrin-Biroulet L, Gilletta C, Allez M, Viennot S, Trang-Poisson C, Laharie D, Amiot A; GETAID-Patient Experience Study Group. Tannoury J, et al. Aliment Pharmacol Ther. 2021 May;53(10):1098-1107. doi: 10.1111/apt.16353. Epub 2021 Apr 5. Aliment Pharmacol Ther. 2021. PMID: 33817819
  • Editorial: determining disability in IBD - 'See(k) and you shall find'.
    Limdi JK. Limdi JK. Aliment Pharmacol Ther. 2021 Jun;53(12):1321-1322. doi: 10.1111/apt.16367. Aliment Pharmacol Ther. 2021. PMID: 34029415 No abstract available.

References

REFERENCES

    1. Limdi JK. Editorial: determining disability in IBD - ‘See(k) and you shall find’. Aliment Pharmacol Ther. 2021;53:1321-1322.
    1. Tannoury J, Nachury M, Martins C, et al. Determinants of IBD-related disability: a cross-sectional survey from the GETAID. Aliment Pharmacol Ther. 2021;53:1098-1107.
    1. Tadbiri S, Nachury M, Bouhnik Y, et al. The IBD-disk is a reliable tool to assess the daily-life burden of patients with inflammatory bowel disease. J Crohns Colitis. 2020. jjaa244. https://doi.org/10.1093/ecco-jcc/jjaa24
    1. Le Berre C, Flamant M, Bouguen G, et al. VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases in a French cohort: the VALIDate study. J Crohns Colitis. 2020;14:1512-1523.
    1. Gower-Rousseau C, Sarter H, Savoye G, et al. Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort. Gut. 2017;66:588-596.

LinkOut - more resources